Maarten B. Rookmaaker

4.0k total citations · 1 hit paper
64 papers, 2.2k citations indexed

About

Maarten B. Rookmaaker is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Maarten B. Rookmaaker has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Nephrology and 14 papers in Surgery. Recurrent topics in Maarten B. Rookmaaker's work include Renal and related cancers (21 papers), Chronic Kidney Disease and Diabetes (8 papers) and Pluripotent Stem Cells Research (8 papers). Maarten B. Rookmaaker is often cited by papers focused on Renal and related cancers (21 papers), Chronic Kidney Disease and Diabetes (8 papers) and Pluripotent Stem Cells Research (8 papers). Maarten B. Rookmaaker collaborates with scholars based in Netherlands, Germany and Switzerland. Maarten B. Rookmaaker's co-authors include Marianne C. Verhaar, Ton J. Rabelink, Anton Jan van Zonneveld, Frank J. T. Staal, Cindy J.M. Loomans, Hetty C. de Boer, C. Verseyden, Branko Braam, Eelco J.P. de Koning and Hans Clevers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physiological Reviews and SHILAP Revista de lepidopterología.

In The Last Decade

Maarten B. Rookmaaker

62 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Progenitor Cell Dysfunction

2004 708 citations Maarten B. Rookmaaker, Hetty C. de Boer et al. profile →

Peers

Countries citing papers authored by Maarten B. Rookmaaker

Since Specialization

Citations

This map shows the geographic impact of Maarten B. Rookmaaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten B. Rookmaaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten B. Rookmaaker more than expected).

Fields of papers citing papers by Maarten B. Rookmaaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten B. Rookmaaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten B. Rookmaaker. The network helps show where Maarten B. Rookmaaker may publish in the future.

Co-authorship network of co-authors of Maarten B. Rookmaaker

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten B. Rookmaaker. A scholar is included among the top collaborators of Maarten B. Rookmaaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten B. Rookmaaker. Maarten B. Rookmaaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell macroencapsulation devices in contemporary research: A systematic review 2025 ·Regenerative Therapy ·(unknown), (unknown), Robin W.M. Vernooij, Marianne C. Verhaar, Maarten B. Rookmaaker	0
2	A semi-permeable insert culture model for the distal part of the nephron with human and mouse tubuloid epithelial cells 2024 ·Experimental Cell Research ·(unknown), (unknown), Fjodor A. Yousef Yengej, Carola M. E. Ammerlaan, Maarten B. Rookmaaker, (unknown), Jitske Jansen, Marianne C. Verhaar, Joost G.J. Hoenderop	0
3	Estimation of renal function immediately after cessation of continuous renal replacement therapy at the ICU 2024 ·Scientific Reports ·(unknown), (unknown), Maaike A. Sikma, Andreas van Arkel, Wouter B. Veldhuis, Marianne C. Verhaar, (unknown), Maarten B. Rookmaaker	1
4	#2514 Clinical impact of the CKD-EPI 2021 versus the CKD-EPI 2012 formula on GFR estimation and CKD prevalence: results from a Dutch routine-care cohort 2024 ·Nephrology Dialysis Transplantation ·(unknown), Maarten B. Rookmaaker, Marianne C. Verhaar, Wouter W. van Solinge, Saskia Haitjema, Robin W.M. Vernooij	1
5	Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease 2024 ·Kidney International ·(unknown), (unknown), Dominique M. Bovée, Maarten B. Rookmaaker, Marianne C. Verhaar, Benito Yard, Ewout J. Hoorn, Jaap A. Joles	3
6	Transcriptomic profile comparison reveals conservation of ionocytes across multiple organs 2023 ·Scientific Reports ·(unknown), Cayetano Pleguezuelos‐Manzano, Maarten B. Rookmaaker, Marianne C. Verhaar, Hans Clevers	14
7	A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats 2021 ·American Journal of Physiology-Renal Physiology ·(unknown), (unknown), Isabella Nguyen, (unknown), (unknown), (unknown), Dominique M. Bovée, Ewout J. Hoorn, Maarten B. Rookmaaker, Karin G. F. Gerritsen, Marianne C. Verhaar, Hendrik Gremmels, Jaap A. Joles	46
8	GFR estimation is complicated by a high incidence of non-steady-state serum creatinine concentrations at the emergency department 2021 ·PLoS ONE ·(unknown), (unknown), Imo E. Hoefer, Marianne C. Verhaar, Jaap A. Joles, Wouter W. van Solinge, Wouter M. Tiel Groenestege, Saskia Haitjema, Maarten B. Rookmaaker	5
9	Modeling Distal Convoluted Tubule (Patho)Physiology: An Overview of Past Developments and an Outlook Toward the Future 2021 ·Tissue Engineering Part C Methods ·(unknown), Fjodor A. Yousef Yengej, Maarten B. Rookmaaker, Marianne C. Verhaar, Jenny van der Wijst, Joost G.J. Hoenderop	5
10	A Perspective on a Urine-Derived Kidney Tubuloid Biobank from Patients with Hereditary Tubulopathies 2021 ·Tissue Engineering Part C Methods ·Frans Schutgens, Maarten B. Rookmaaker, Marianne C. Verhaar	8
11	Early Estimation of Renal Function After Transplantation to Enable Appropriate Dosing of Critical Drugs: Retrospective Analysis of 103 Patients in a Single Center 2020 ·Clinical Pharmacokinetics ·(unknown), (unknown), Arjan D. van Zuilen, Marianne C. Verhaar, Alwin D. R. Huitema, Maarten B. Rookmaaker	5
12	Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND 2020 ·PLoS ONE ·Joep van der Leeuw, Martin H. de Borst, Lyanne M. Kieneker, Stephan J. L. Bakker, Ron T. Gansevoort, Maarten B. Rookmaaker	10
13	Dalteparin and anti-Xa: a complex interplay of therapeutic drug monitoring. 2019 ·PubMed ·(unknown), Albert Huisman, (unknown), (unknown), Maarten B. Rookmaaker, H. A. H. Kaasjager, Mathilde Nijkeuter	6
14	Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology 2016 ·European Journal of Pharmacology ·Frans Schutgens, Marianne C. Verhaar, Maarten B. Rookmaaker	35
15	Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney disease 2014 ·Nephrology Dialysis Transplantation ·Niek F. Casteleijn, Edwin M. Spithoven, Maarten B. Rookmaaker, Mervyn D. I. Vergouwen, Ron T. Gansevoort	2
16	Eligibility for percutaneous renal denervation 2013 ·Journal of Hypertension ·Willemien L. Verloop, Eva E. Vink, Michiel Voskuil, Evert‐Jan Vonken, Maarten B. Rookmaaker, Michiel L. Bots, Pieter A. Doevendans, Peter J. Blankestijn, Wilko Spiering	32
17	Solid renal tumours of collecting duct origin in patients on chronic lithium therapy 2012 ·Clinical Kidney Journal ·Maarten B. Rookmaaker, (unknown), R. Goldschmeding, Walther H. Boer	20
18	ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling 2012 ·SHILAP Revista de lepidopterología ·Peter E. Westerweel, Jaap A. Joles, Krista den Ouden, Roel Goldschmeding, Maarten B. Rookmaaker, Marianne C. Verhaar	4
19	Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo 2007 ·American Journal of Physiology-Renal Physiology ·Maarten B. Rookmaaker, Marianne C. Verhaar, Hetty C. de Boer, Roel Goldschmeding, Jaap A. Joles, Hein A. Koomans, Hermann-Josef Gröne, Ton J. Rabelink	27
20	Progenitor cells in the kidney: Biology and therapeutic perspectives 2004 ·Kidney International ·Maarten B. Rookmaaker, Marianne C. Verhaar, Anton Jan van Zonneveld, Ton J. Rabelink	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact